Early Phase 1
Completed N=58
Lavender vs Zolpidem Sleep Quality During Diagnostic PSG
Sleep
Source: ClinicalTrials.gov NCT04102345 ↗
Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcomePrimary: Sleep Efficiency — 77.6; 76.8 percentage of time in bed sleeping
Summary
In this pragmatic, clinical study the investigators propose that lavender aromatherapy is comparable to Zolpidem (Ambien) in improving the quality of diagnostic sleep studies.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Sleep Efficiency |
77.6; 76.8 | — |
| SECONDARY Number of Participants With A Successful Polysomnogram (PSG) |
24; 28 | — |
| SECONDARY Wake After Sleep Onset (WASO) |
52.3; 53.7 | — |
Eligibility Criteria
Inclusion Criteria
- Age >=18 years
- In-center diagnostic or split night sleep study (PSG)
Exclusion Criteria
- No exclusion criteria
Data sourced from ClinicalTrials.gov (NCT04102345). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.